FILE PHOTO: An advertisement is played on a set of large screens at the Microsoft office in Cambridge, Massachusetts, U.S., on January 25, 2017. REUTERS/Brian Snyder/File Photo
Oxford Biomedica Plc is working with software giant Microsoft Corp on developing better ways of repairing the genes of people with life-threatening diseases.
Microsoft will use its Azure cloud and machine-learning software to develop ways to increase the productivity and purity of viruses that UK-based Oxford Biomedica makes to carry healthy genetic sequences into cells with broken and malformed genes, according to an emailed statement. The collaboration will last for two years and can be extended.
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
